{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:19Z","timestamp":1792785019337,"version":"4.5.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T00:00:00Z","timestamp":1754524800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["81401952"],"award-info":[{"award-number":["81401952"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Tianjin Key Medical Discipline(Specialty) Construction Project","award":["TJYXZDXK-009A"],"award-info":[{"award-number":["TJYXZDXK-009A"]}]},{"name":"Tianjin Key Medical Discipline(Specialty) Construction Project","award":["TJYXZDXK-009A"],"award-info":[{"award-number":["TJYXZDXK-009A"]}]},{"name":"Tianjin Key Medical Discipline(Specialty) Construction Project","award":["TJYXZDXK-009A"],"award-info":[{"award-number":["TJYXZDXK-009A"]}]},{"name":"Tianjin Key Medical Discipline(Specialty) Construction Project","award":["TJYXZDXK-009A"],"award-info":[{"award-number":["TJYXZDXK-009A"]}]},{"name":"Tianjin Key Medical Discipline(Specialty) Construction Project","award":["TJYXZDXK-009A"],"award-info":[{"award-number":["TJYXZDXK-009A"]}]},{"name":"Tianjin Key Medical Discipline(Specialty) Construction Project","award":["TJYXZDXK-009A"],"award-info":[{"award-number":["TJYXZDXK-009A"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-14342-z","type":"journal-article","created":{"date-parts":[[2025,8,7]],"date-time":"2025-08-07T16:27:39Z","timestamp":1754584059000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pan-cancer landscape of ITGAV and its potential role in gastric cancer"],"prefix":"10.1038","volume":"15","author":[{"given":"Bin","family":"Ke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peng","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-Jun","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ru-peng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ning","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,8,7]]},"reference":[{"key":"14342_CR1","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA: A Cancer J. Clini. 74, 229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834 (2024).","journal-title":"CA: A Cancer J. Clini."},{"key":"14342_CR2","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.jncc.2024.01.006","volume":"4","author":"B Han","year":"2024","unstructured":"Han, B. et al. Cancer incidence and mortality in China, 2022. JNCC 4, 47\u201353. https:\/\/doi.org\/10.1016\/j.jncc.2024.01.006 (2024).","journal-title":"JNCC"},{"key":"14342_CR3","doi-asserted-by":"publisher","first-page":"153303382412719","DOI":"10.1177\/15330338241271935","volume":"23","author":"M Wu","year":"2024","unstructured":"Wu, M., Yuan, S., Liu, K., Wang, C. & Wen, F. Gastric cancer signaling pathways and therapeutic applications. Technol. Cancer Res. Treat. 23, 15330338241271936. https:\/\/doi.org\/10.1177\/15330338241271935 (2024).","journal-title":"Technol. Cancer Res. Treat."},{"key":"14342_CR4","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/s0092-8674(02)00971-6","volume":"110","author":"RO Hynes","year":"2002","unstructured":"Hynes, R. O. Integrins: Bidirectional, allosteric signaling machines. Cell 110, 673\u2013687. https:\/\/doi.org\/10.1016\/s0092-8674(02)00971-6 (2002).","journal-title":"Cell"},{"key":"14342_CR5","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s12551-013-0123-1","volume":"6","author":"LR Anderson","year":"2014","unstructured":"Anderson, L. R., Owens, T. W. & Naylor, M. J. Integrins in development and cancer. Biophys. Rev. 6, 191\u2013202. https:\/\/doi.org\/10.1007\/s12551-013-0123-1 (2014).","journal-title":"Biophys. Rev."},{"key":"14342_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s12282-024-01635-w","author":"Q Huang","year":"2024","unstructured":"Huang, Q., Wang, J., Ning, H., Liu, W. & Han, X. Integrin \u03b21 in breast cancer: mechanisms of progression and therapy. Breast Cancer (Tokyo, Japan) https:\/\/doi.org\/10.1007\/s12282-024-01635-w (2024).","journal-title":"Breast Cancer (Tokyo, Japan)"},{"key":"14342_CR7","doi-asserted-by":"publisher","first-page":"a006478","DOI":"10.1101\/cshperspect.a006478","volume":"1","author":"SM Weis","year":"2011","unstructured":"Weis, S. M. & Cheresh, D. A. \u03b1V integrins in angiogenesis and cancer. Cold Spring Harb. Perspect. Med. 1, a006478. https:\/\/doi.org\/10.1101\/cshperspect.a006478 (2011).","journal-title":"Cold Spring Harb. Perspect. Med."},{"key":"14342_CR8","first-page":"211","volume":"10","author":"IW Cheuk","year":"2020","unstructured":"Cheuk, I. W. et al. ITGAV targeting as a therapeutic approach for treatment of metastatic breast cancer. Am. J. Cancer Res. 10, 211\u2013223 (2020).","journal-title":"Am. J. Cancer Res."},{"key":"14342_CR9","doi-asserted-by":"publisher","first-page":"18411","DOI":"10.1038\/s41598-020-75085-7","volume":"10","author":"H Loeser","year":"2020","unstructured":"Loeser, H. et al. Integrin alpha V (ITGAV) expression in esophageal adenocarcinoma is associated with shortened overall-survival. Sci. Rep. 10, 18411. https:\/\/doi.org\/10.1038\/s41598-020-75085-7 (2020).","journal-title":"Sci. Rep."},{"key":"14342_CR10","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.3390\/curroncol31030099","volume":"31","author":"L Xu","year":"2024","unstructured":"Xu, L. et al. ITGAV promotes the progression of head and neck squamous cell carcinoma. Curr. Oncol. 31, 1311\u20131322. https:\/\/doi.org\/10.3390\/curroncol31030099 (2024).","journal-title":"Curr. Oncol."},{"key":"14342_CR11","doi-asserted-by":"publisher","DOI":"10.3390\/ijms232012346","author":"E Brzozowska","year":"2022","unstructured":"Brzozowska, E. & Deshmukh, S. Integrin alpha v beta 6 (\u03b1v\u03b26) and its implications in cancer treatment. Int. J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms232012346 (2022).","journal-title":"Int. J. Mol. Sci."},{"key":"14342_CR12","doi-asserted-by":"publisher","first-page":"5863","DOI":"10.1016\/j.asjsur.2023.08.171","volume":"46","author":"W Zhang","year":"2023","unstructured":"Zhang, W., Chen, Y., Qiao, Z. & Liu, Y. Overexpression of Integrin alpha V (ITGAV) in gastric cancer and its prognostic significance. Asian J. Surg. 46, 5863\u20135864. https:\/\/doi.org\/10.1016\/j.asjsur.2023.08.171 (2023).","journal-title":"Asian J. Surg."},{"key":"14342_CR13","doi-asserted-by":"publisher","first-page":"152531","DOI":"10.1016\/j.prp.2019.152531","volume":"215","author":"H Wang","year":"2019","unstructured":"Wang, H. et al. Integrin subunit alpha V promotes growth, migration, and invasion of gastric cancer cells. Pathol. Res. Pract. 215, 152531. https:\/\/doi.org\/10.1016\/j.prp.2019.152531 (2019).","journal-title":"Pathol. Res. Pract."},{"key":"14342_CR14","first-page":"388","volume":"15","author":"ZZ Chen","year":"2022","unstructured":"Chen, Z. Z., Wang, W. P., Xue, H. M. & Liang, Y. The lncRNA-miRNA-integrin alpha V ceRNA network can affect the occurrence and prognosis of gastric cancer. Int. J. Clin. Exp. Pathol. 15, 388\u2013402 (2022).","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"14342_CR15","doi-asserted-by":"publisher","first-page":"e70087","DOI":"10.1002\/cnr2.70087","volume":"7","author":"M Piroozkhah","year":"2024","unstructured":"Piroozkhah, M., Zabihi, M., Jalali, P. & Salehi, Z. Comprehensive multi-omics analysis reveals NPC2 and ITGAV genes as potential prognostic biomarkers in gastrointestinal cancers. Cancer Rep. (Hoboken, NJ) 7, e70087. https:\/\/doi.org\/10.1002\/cnr2.70087 (2024).","journal-title":"Cancer Rep. (Hoboken, NJ)"},{"key":"14342_CR16","doi-asserted-by":"publisher","first-page":"1480771","DOI":"10.3389\/fimmu.2025.1480771","volume":"16","author":"X Shi","year":"2025","unstructured":"Shi, X. et al. Comprehensive analysis of the multifaceted role of ITGAV in digestive system cancer progression and immune infiltration. Front. Immunol. 16, 1480771. https:\/\/doi.org\/10.3389\/fimmu.2025.1480771 (2025).","journal-title":"Front. Immunol."},{"key":"14342_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.heliyon.2024.e32291","volume":"10","author":"B Ke","year":"2024","unstructured":"Ke, B. et al. Oncogenic and immunological role of EDIL3 in human tumours: From pan-cancer analysis to validation in gastric cancer. Heliyon 10, e32291. https:\/\/doi.org\/10.1016\/j.heliyon.2024.e32291 (2024).","journal-title":"Heliyon"},{"key":"14342_CR18","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.693","volume":"5","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. Cell death pathways: Molecular mechanisms and therapeutic targets for cancer. MedComm 5, e693. https:\/\/doi.org\/10.1002\/mco2.693 (2024).","journal-title":"MedComm"},{"key":"14342_CR19","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1158\/2159-8290.Cd-24-0296","volume":"14","author":"M Esteller","year":"2024","unstructured":"Esteller, M. et al. The Epigenetic hallmarks of cancer. Cancer Discov. 14, 1783\u20131809. https:\/\/doi.org\/10.1158\/2159-8290.Cd-24-0296 (2024).","journal-title":"Cancer Discov."},{"key":"14342_CR20","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1038\/s41467-017-01198-9","volume":"8","author":"H Hieronymus","year":"2017","unstructured":"Hieronymus, H. et al. Deletion of 3p13-14 locus spanning FOXP1 to SHQ1 cooperates with PTEN loss in prostate oncogenesis. Nat. Commun. 8, 1081. https:\/\/doi.org\/10.1038\/s41467-017-01198-9 (2017).","journal-title":"Nat. Commun."},{"key":"14342_CR21","doi-asserted-by":"publisher","first-page":"276","DOI":"10.4240\/wjgs.v16.i2.276","volume":"16","author":"HQ Cai","year":"2024","unstructured":"Cai, H. Q., Zhang, L. Y., Fu, L. M., Xu, B. & Jiao, Y. Mutational landscape of TP53 and CDH1 in gastric cancer. World J. Gastrointest. Surg. 16, 276\u2013283. https:\/\/doi.org\/10.4240\/wjgs.v16.i2.276 (2024).","journal-title":"World J. Gastrointest. Surg."},{"key":"14342_CR22","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1186\/s12885-022-09801-z","volume":"22","author":"S Xu","year":"2022","unstructured":"Xu, S. et al. N6-methyladenosine-related lncRNAs identified as potential biomarkers for predicting the overall survival of Asian gastric cancer patients. BMC Cancer 22, 721. https:\/\/doi.org\/10.1186\/s12885-022-09801-z (2022).","journal-title":"BMC Cancer"},{"key":"14342_CR23","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1038\/s41392-020-00449-4","volume":"6","author":"T Tang","year":"2021","unstructured":"Tang, T. et al. Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy. Signal Transduct. Target. Ther. 6, 72. https:\/\/doi.org\/10.1038\/s41392-020-00449-4 (2021).","journal-title":"Signal Transduct. Target. Ther."},{"key":"14342_CR24","doi-asserted-by":"publisher","first-page":"926","DOI":"10.1080\/15548627.2022.2113296","volume":"19","author":"V Muir","year":"2023","unstructured":"Muir, V. et al. Transcriptomic analysis of pathways associated with ITGAV\/alpha(v) integrin-dependent autophagy in human B cells. Autophagy 19, 926\u2013942. https:\/\/doi.org\/10.1080\/15548627.2022.2113296 (2023).","journal-title":"Autophagy"},{"key":"14342_CR25","doi-asserted-by":"publisher","first-page":"5947","DOI":"10.1126\/science.aay5947","volume":"367","author":"E Sj\u00f6stedt","year":"2020","unstructured":"Sj\u00f6stedt, E. et al. An atlas of the protein-coding genes in the human, pig, and mouse brain. Science 367, 5947. https:\/\/doi.org\/10.1126\/science.aay5947 (2020).","journal-title":"Science"},{"key":"14342_CR26","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.neo.2022.01.001","volume":"25","author":"DS Chandrashekar","year":"2022","unstructured":"Chandrashekar, D. S. et al. UALCAN: An update to the integrated cancer data analysis platform. Neoplasia 25, 18\u201327. https:\/\/doi.org\/10.1016\/j.neo.2022.01.001 (2022).","journal-title":"Neoplasia"},{"key":"14342_CR27","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1038\/s41586-019-1186-3","volume":"569","author":"M Ghandi","year":"2019","unstructured":"Ghandi, M. et al. Next-generation characterization of the cancer cell line encyclopedia. Nature 569, 503\u2013508. https:\/\/doi.org\/10.1038\/s41586-019-1186-3 (2019).","journal-title":"Nature"},{"key":"14342_CR28","doi-asserted-by":"publisher","DOI":"10.1002\/cpbi.5","author":"G Stelzer","year":"2016","unstructured":"Stelzer, G. et al. The GeneCards suite: From gene data mining to disease genome sequence analyses. Curr. Protoc. Bioinform. https:\/\/doi.org\/10.1002\/cpbi.5 (2016).","journal-title":"Curr. Protoc. Bioinform."},{"key":"14342_CR29","doi-asserted-by":"publisher","first-page":"D1425","DOI":"10.1093\/nar\/gkac959","volume":"51","author":"Y Han","year":"2023","unstructured":"Han, Y. et al. TISCH2: expanded datasets and new tools for single-cell transcriptome analyses of the tumor microenvironment. Nucleic Acids Res. 51, D1425-d1431. https:\/\/doi.org\/10.1093\/nar\/gkac959 (2023).","journal-title":"Nucleic Acids Res."},{"key":"14342_CR30","doi-asserted-by":"publisher","first-page":"3861","DOI":"10.1158\/0008-5472.Can-23-0816","volume":"83","author":"I de Bruijn","year":"2023","unstructured":"de Bruijn, I. et al. Analysis and visualization of longitudinal genomic and clinical data from the AACR project GENIE biopharma collaborative in cBioPortal. Can. Res. 83, 3861\u20133867. https:\/\/doi.org\/10.1158\/0008-5472.Can-23-0816 (2023).","journal-title":"Can. Res."},{"key":"14342_CR31","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbac558","author":"CJ Liu","year":"2023","unstructured":"Liu, C. J. et al. GSCA: an integrated platform for gene set cancer analysis at genomic, pharmacogenomic and immunogenomic levels. Brief. Bioinform. https:\/\/doi.org\/10.1093\/bib\/bbac558 (2023).","journal-title":"Brief. Bioinform."},{"key":"14342_CR32","doi-asserted-by":"publisher","first-page":"277","DOI":"10.2217\/epi-2017-0118","volume":"10","author":"V Modhukur","year":"2018","unstructured":"Modhukur, V. et al. MethSurv: A web tool to perform multivariable survival analysis using DNA methylation data. Epigenomics 10, 277\u2013288. https:\/\/doi.org\/10.2217\/epi-2017-0118 (2018).","journal-title":"Epigenomics"},{"key":"14342_CR33","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson, V. et al. The immune landscape of cancer. Immunity 48, 812-830.e814. https:\/\/doi.org\/10.1016\/j.immuni.2018.03.023 (2018).","journal-title":"Immunity"},{"key":"14342_CR34","doi-asserted-by":"publisher","DOI":"10.1200\/po.17.00073","author":"R Bonneville","year":"2017","unstructured":"Bonneville, R. et al. Landscape of microsatellite instability across 39 cancer types. JCO Precis. Oncol. https:\/\/doi.org\/10.1200\/po.17.00073 (2017).","journal-title":"JCO Precis. Oncol."},{"key":"14342_CR35","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li, T. et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 48, 509\u2013514. https:\/\/doi.org\/10.1093\/nar\/gkaa407 (2020).","journal-title":"Nucleic Acids Res."},{"key":"14342_CR36","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D. et al. The STRING database in 2023: Protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 51, D638-d646. https:\/\/doi.org\/10.1093\/nar\/gkac1000 (2023).","journal-title":"Nucleic Acids Res."},{"key":"14342_CR37","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330. https:\/\/doi.org\/10.1093\/nar\/28.1.27 (2000).","journal-title":"Nucleic Acids Res."},{"key":"14342_CR38","doi-asserted-by":"publisher","first-page":"108648","DOI":"10.1016\/j.isci.2023.108648","volume":"27","author":"X Zhou","year":"2024","unstructured":"Zhou, X., Xiao, B., Jiang, M. & Rui, J. Pan-cancer analysis identifies EMC6 as a potential target for lung adenocarcinoma. iScience 27, 108648. https:\/\/doi.org\/10.1016\/j.isci.2023.108648 (2024).","journal-title":"iScience"},{"key":"14342_CR39","doi-asserted-by":"publisher","first-page":"3932","DOI":"10.7150\/jca.42900","volume":"11","author":"B Ke","year":"2020","unstructured":"Ke, B. et al. Sonic Hedgehog\/Gli1 signaling pathway regulates cell migration and invasion via induction of epithelial-to-mesenchymal transition in gastric cancer. J. Cancer 11, 3932\u20133943. https:\/\/doi.org\/10.7150\/jca.42900 (2020).","journal-title":"J. Cancer"},{"key":"14342_CR40","doi-asserted-by":"publisher","first-page":"e15559","DOI":"10.7717\/peerj.15559","volume":"11","author":"B Ke","year":"2023","unstructured":"Ke, B. et al. EDIL3 is a potential prognostic biomarker that correlates with immune infiltrates in gastric cancer. PeerJ 11, e15559. https:\/\/doi.org\/10.7717\/peerj.15559 (2023).","journal-title":"PeerJ"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14342-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14342-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14342-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T05:02:04Z","timestamp":1754629324000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-14342-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8,7]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["14342"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-14342-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,8,7]]},"assertion":[{"value":"2 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"30 July 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 August 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"This study was approved by the Ethics Committee of Tianjin cancer hospital (No.bc2023054) and written informed consent was obtained from all patients. All methods in this study were performed in accordance with the principles of the Declaration of Helsinki and current ethical guidelines.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}],"article-number":"28934"}}